Impact News +++ Ad-hoc News: ABO Energy GmbH & Co. KGaA (EQS) +++ ABO ENERGY Aktie +3,57%

INOVIO Aktie

>INOVIO Aktienkurs

0.555 EUR -2.8% (TradegateBSX)

Ask: 0.591 EUR / 8500 Stück

Bid: 0.573 EUR / 8800 Stück

Tagesumsatz: 4220 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INOVIO Aktie über LYNX handeln

Intraday

1 Jahr

>INOVIO Performance

1 Woche: -39,8%

1 Monat: -42,4%

3 Monate: -41,8%

6 Monate: -59,6%

1 Jahr: -56,1%

laufendes Jahr: -62,6%

>INOVIO Aktie

Profil:

Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing DNA medicines for treating and protecting against HPV-related diseases, cancer, and infectious diseases. The company employs proprietar..
>Volltext..

Insiderhandel:

>INOVIO Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>INOVIO Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika

>INOVIO Chart & Kurs - NASDAQ

>INOVIO News

30.07.26 - 15:18	Verwässernde Kapitalerhöhung: Inovio Aktie stürzt um 30 % ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 06:42	Inovio slumps 22% on pricing $20M stock offering (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 03:00	INOVIO Announces Pricing of $20.0 Million Public Offering (PR Newswire)
	PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the......

29.07.26 - 22:06	INOVIO Announces Proposed Public Offering (PR Newswire)
	PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced......

04.06.26 - 22:39	Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm (PR Newswire)
	NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit,......

28.05.26 - 14:09	INOVIO to Participate in Upcoming Scientific and Investor Conferences (PR Newswire)
	PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in......

22.05.26 - 18:39	Inovio gains on late-stage trial win for DNA shot (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.05.26 - 22:06	Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO′s Partner in China (PR Newswire)
	Results provide important clinical evidence to support ApolloBio's future regulatory submission in China of VGX-3100, INOVIO's DNA immunotherapy candidate ApolloBio's new clinical results further highlight the potential of INOVIO's DNA medicine platform to treat diseases caused by......

19.05.26 - 14:12	Inovio übertrifft Gewinnprognose für Q1 2026, Aktie fällt dennoch (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

14.05.26 - 03:33	Inovio outlines cash runway into Q1 2027 as INO-3107 targets October 30, 2026 PDUFA date (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.05.26 - 01:45	Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call (Benzinga)
	Importance Rank: 1 read more...

14.05.26 - 00:12	Inovio (INO) Q1 2026 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

13.05.26 - 23:36	Earnings Call: Inovio meldet klinische Fortschritte für Q1 2026, Aktie legt um 2,84 % zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

13.05.26 - 22:30	Earnings Snapshot: Inovio Pharmaceuticals′ Q1 shows EPS beat; net loss $19.7M improves as R&D costs fall (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.05.26 - 22:12	Inovio Pharmaceuticals GAAP EPS of -$0.28 beats by $0.07 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.05.26 - 22:09	INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights (PR Newswire)
	Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA) with a target Prescription Drug User Fee Act (PDUFA) date of October 30, 2026 Commercial readiness plans continue to advance in......

08.05.26 - 14:09	INOVIO to Participate in Upcoming Scientific Conferences (PR Newswire)
	PLYMOUTH MEETING, Pa., May 8, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in......

01.05.26 - 22:09	INOVIO to Report First Quarter Financial Results on May 13, 2026 (PR Newswire)
	PLYMOUTH MEETING, Pa., May 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that its first quarter 2026......

07.04.26 - 20:54	INO Deadline Today: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, April 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 7, 2026......

06.04.26 - 09:49	Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO (PR Newswire)
	LOS ANGELES, April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or "the Company") (NASDAQ: INO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Ein Bauer, der den ganzen Wald schlägert, ist auf dem Holzweg. - Dr. Fritz P. Rinnhofer

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram